PrednisoneVincristineCyclophosphamideGlucocorticoidsDoxorubicinProcarbazineAntineoplastic Combined Chemotherapy ProtocolsMechlorethaminePrednisoloneAzathioprineImmunosuppressive AgentsTreatment OutcomeMelphalanMitoxantroneDrug Therapy, CombinationAntibodies, Monoclonal, Murine-DerivedAnti-Inflammatory AgentsDrug Administration ScheduleBleomycinMethotrexateColor TherapyRemission InductionChlorambucilLymphoma, Non-HodgkinCyclosporineHodgkin DiseaseLymphoma, Large B-Cell, DiffuseAdministration, OralMycophenolic AcidVinblastineAdrenal Cortex HormonesAsparaginaseFollow-Up StudiesThalidomideMultiple MyelomaKidney TransplantationTime FactorsEtoposideSurvival AnalysisGraft RejectionRecurrenceTacrolimusDisease-Free SurvivalMethylprednisoloneSurvival RateCombined Modality TherapyNephrotic SyndromeCyclosporinsPolymyalgia Rheumatica6-MercaptopurineEtiocholanoloneLymphoma, FollicularDose-Response Relationship, DrugVindesineClinical Trials as TopicCarmustineAndrostenolsTaxoidsPrognosisProspective StudiesRetrospective StudiesAdrenocortical HyperfunctionImmunosuppressionRaccoon DogsDouble-Blind MethodCapillary FragilityLomustineDexamethasoneBoronic AcidsEstramustineThrombocytopeniaPyrazinesPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Agents, HormonalGraft SurvivalRemission, SpontaneousArthritis, RheumatoidProstatic NeoplasmsOrchiectomyFluoxymesteroneAntibodies, Monoclonal